Real-time attack of LL-37 on single Bacillus subtilis cells.
Barns. Kenneth J KJ; Weisshaar. James C JC
Key Findings
- At 2 µM LL‑37, B. subtilis cells grow slower but their membranes stay intact.
- At 4 µM LL‑37, cells rapidly lose turgor pressure, become permeable to dye, and shrink, indicating lethal membrane damage.
- The damage caused at 4 µM is not reversible after the peptide is removed, whereas the growth slowdown at 2 µM recovers.
Practical Outcomes
- For DIY health enthusiasts, the data suggest that LL‑37 can act as a bacteriostatic agent at low concentrations and a bactericidal agent at higher concentrations. However, the work is limited to a single lab strain of bacteria and does not address safety or efficacy in humans, so it offers only modest guidance for any supplementation or topical use protocols.
Summary
The study shows that the human antimicrobial peptide LL‑37 kills Bacillus subtilis bacteria in a dose‑dependent way: low levels (2 µM) just slow bacterial growth, while higher levels (4 µM) quickly break the cell membrane and kill the bacteria irreversibly.
Abstract
Time-lapse fluorescence microscopy of single, growing Bacillus subtilis cells with 2-12s time resolution reveals the mechanisms of antimicrobial peptide (AMP) action on a Gram-positive species with unprecedented detail. For the human cathelicidin LL-37 attacking B. subtilis, the symptoms of antimicrobial stress differ dramatically depending on the bulk AMP concentration. At 2μM LL-37, the mean single-cell growth rate decreases, but membrane permeabilization does not occur. At 4μM LL-37, cells abruptly shrink in size at the same time that Sytox Green enters the cytoplasm and stains the nucleoids. We interpret the shrinkage event as loss of turgor pressure (and presumably the membrane potential) due to permeabilization of the membrane. Movies of Sytox Green staining at 0.5frame/s show that nucleoid staining is initially local, more consistent with pore formation than with global permeabilization models. In a novel "growth recovery" assay, cells are incubated with LL-37 for a variable period and then rinsed with fresh growth medium lacking LL-37. The growth rate attenuation observed at 2μM LL-37 is a recoverable symptom, while the abrupt cell shrinkage observed at 4μM LL-37 is not.
Study Information
pubmed
2013
2013-02-26T00:00:00.000Z
10.1016/j.bbamem.2013.02.011
78
37